Cargando…
Retinal Gene Therapy: Surgical Vector Delivery in the Translation to Clinical Trials
An exceptionally high number of monogenic disorders lead to incurable blindness, making them targets for the development of gene-therapy. In order to successfully apply therapeutic vector systems in vivo, the heterogeneity of the disease phenotype needs to be considered. This necessitates tailored a...
Autores principales: | Ochakovski, G. Alex, Bartz-Schmidt, K. Ulrich, Fischer, M. Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376580/ https://www.ncbi.nlm.nih.gov/pubmed/28420956 http://dx.doi.org/10.3389/fnins.2017.00174 |
Ejemplares similares
-
An Optimized Treatment Protocol for Subretinal Injections Limits Intravitreal Vector Distribution
por: Reichel, Felix F.L., et al.
Publicado: (2021) -
Longitudinal Evaluation of Hyper-Reflective Foci in the Retina Following Subretinal Delivery of Adeno-Associated Virus in Non-Human Primates
por: Rodríguez-Bocanegra, Eduardo, et al.
Publicado: (2021) -
Pre-clinical delivery of gene therapy products to the cerebrospinal fluid: challenges and considerations for clinical translation
por: Salegio, Ernesto A., et al.
Publicado: (2023) -
Technique of retinal gene therapy: delivery of viral vector into the subretinal space
por: Xue, K, et al.
Publicado: (2017) -
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation
por: Rincon, Melvin Y., et al.
Publicado: (2015)